Marta Černá

Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes

L. Forétova, P. Dundr, R. Storchová, 2020, Biomedicines.

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer

L. Forétova, M. Zikan, S. Kmoch, 2020, Cancers.

Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer

K. Křížová, J. Kotlas, S. Kmoch, 2019, International journal of cancer.

Low Frequency of Cancer-Predisposition Gene Mutations in Liver Transplant Candidates with Hepatocellular Carcinoma

T. Zima, M. Kalousová, P. Kleiblova, 2022, Cancers.

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

James M. Hodge, E. Burnside, Y. Kamatani, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

A comprehensive analysis of germline predisposition to early-onset ovarian cancer

P. Kleiblova, J. Soukupová, Z. Kleibl, 2024, Scientific reports.

Population-specific validation and comparison of the performance of 77- and 313-variant polygenic risk scores for breast cancer risk prediction.

M. Kalousová, P. Kleiblova, J. Soukupová, 2024, Cancer.